Cencora Inc. (COR)

Name: Cencora Inc. (COR) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Health Care · Wall Street (EE. UU.) · Última actualización: 2026-09-06

Cencora, Inc. obtiene y distribuye productos farmacéuticos en los Estados Unidos e internacionalmente. El segmento de Soluciones de Atención Médica de EE. UU.

Traducido automáticamente

Cifras clave

Capitalización bursátil: $59 billion
Ingresos (ejercicio cerrado en 2025-09-30): $321.3B
Beneficio neto: $1.6B
Margen bruto: 3.2%
Margen neto: 0.5%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Ingresos totales	$332.8B	$321.3B	$294.0B	$262.2B	$238.6B	$214.0B	$189.9B	$179.6B	$167.9B	$153.1B	$146.8B	$136.0B	$119.6B	$88.0B	$79.5B	$80.2B	$78.0B	$71.8B	$70.2B	$66.1B	$61.2B
Beneficio bruto	$12.3B	$10.1B	$8.7B	$7.8B	$7.6B	$6.3B	$4.8B	$4.5B	$4.1B	$4.1B	$3.8B	$3.2B	$2.8B	$2.3B	$2.5B	$2.4B	$2.2B	$2.0B	$1.9B	$2.2B	$2.1B
% de margen bruto	3.7%	3.2%	3.0%	3.0%	3.2%	2.9%	2.5%	2.5%	2.5%	2.7%	2.6%	2.4%	2.3%	2.6%	3.2%	3.0%	2.9%	2.8%	2.8%	3.3%	3.4%
Ingresos operativos (EBIT)	$4.3B	$3.6B	$3.0B	$2.4B	$2.8B	$2.7B	$2.0B	$1.9B	$1.7B	$2.0B	$1.7B	$1.3B	$1.2B	$989M	$1.3B	$1.2B	$1.1B	$899M	$824M	$787M	$728M
% de margen operativo	1.3%	1.1%	1.0%	0.9%	1.1%	1.2%	1.1%	1.0%	1.0%	1.3%	1.1%	1.0%	1.0%	1.1%	1.6%	1.5%	1.4%	1.2%	1.2%	1.2%	1.2%
Ingresos netos	$2.6B	$1.6B	$1.5B	$1.7B	$1.7B	$1.5B	($3.4B)	$855M	$1.7B	$414M	$1.4B	($135M)	$276M	$434M	$719M	$707M	$637M	$503M	$251M	$469M	$468M
% de margen neto	0.8%	0.5%	0.5%	0.7%	0.7%	0.7%	-1.8%	0.5%	1.0%	0.3%	1.0%	-0.1%	0.2%	0.5%	0.9%	0.9%	0.8%	0.7%	0.4%	0.7%	0.8%
EBITDA	$5.1B	$3.7B	$3.4B	$3.4B	$3.1B	$2.9B	($4.7B)	$1.7B	$1.9B	$1.5B	$1.9B	$631M	$939M	$1.1B	$1.4B	$1.3B	$1.2B	$978M	$929M	$960M	$846M
Beneficio por acción (EPS)	$13.45	$7.96	$7.53	$8.53	$8.04	$7.39	$-16.60	$4.04	$7.53	$1.87	$6.32	$-0.62	$1.17	$1.84	$2.80	$2.54	$2.22	$1.66	$0.77	$1.25	$1.13
Acciones en circulación (M)	194M	195M	200M	205M	211M	208M	205M	212M	220M	222M	226M	218M	235M	235M	257M	278M	287M	303M	325M	376M	415M

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de COR. /companies/us/COR

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.